114 results on '"Woolard, Kevin"'
Search Results
102. Identification of a polyomavirus microRNA highly expressed in tumors
- Author
-
Chen, Chun Jung, primary, Cox, Jennifer E., additional, Azarm, Kristopher D., additional, Wylie, Karen N., additional, Woolard, Kevin D., additional, Pesavento, Patricia A., additional, and Sullivan, Christopher S., additional
- Published
- 2015
- Full Text
- View/download PDF
103. ZFHX4 Interacts with the NuRD Core Member CHD4 and Regulates the Glioblastoma Tumor-Initiating Cell State
- Author
-
David H. Koch Institute for Integrative Cancer Research at MIT, Chudnovsky, Yakov, Kim, Dohoon, Whyte, Warren A., Thiru, Prathapan, Muffat, Julien, Yilmaz, Omer, Mitalipova, Maya, Young, Richard A., Sabatini, David M., Zheng, Siyuan, Bansal, Mukesh, Bray, Mark-Anthony, Gopal, Shuba, Theisen, Matthew A., Bilodeau, Steve, Woolard, Kevin, Lee, Jeongwu, Nishimura, Riko, Sakata, Nobuo, Fine, Howard A., Carpenter, Anne E., Silver, Serena J., Verhaak, Roel G.W., Califano, Andrea, Ligon, Keith L., Mellinghoff, Ingo K., Root, David E., Hahn, William C., Chheda, Milan G., David H. Koch Institute for Integrative Cancer Research at MIT, Chudnovsky, Yakov, Kim, Dohoon, Whyte, Warren A., Thiru, Prathapan, Muffat, Julien, Yilmaz, Omer, Mitalipova, Maya, Young, Richard A., Sabatini, David M., Zheng, Siyuan, Bansal, Mukesh, Bray, Mark-Anthony, Gopal, Shuba, Theisen, Matthew A., Bilodeau, Steve, Woolard, Kevin, Lee, Jeongwu, Nishimura, Riko, Sakata, Nobuo, Fine, Howard A., Carpenter, Anne E., Silver, Serena J., Verhaak, Roel G.W., Califano, Andrea, Ligon, Keith L., Mellinghoff, Ingo K., Root, David E., Hahn, William C., and Chheda, Milan G.
- Abstract
Glioblastoma (GBM) harbors subpopulations of therapy-resistant tumor-initiating cells (TICs) that are self-renewing and multipotent. To understand the regulation of the TIC state, we performed an image-based screen for genes regulating GBM TIC maintenance and identified ZFHX4, a 397 kDa transcription factor. ZFHX4 is required to maintain TIC-associated and normal human neural precursor cell phenotypes in vitro, suggesting that ZFHX4 regulates differentiation, and its suppression increases glioma-free survival in intracranial xenografts. ZFHX4 interacts with CHD4, a core member of the nucleosome remodeling and deacetylase (NuRD) complex. ZFHX4 and CHD4 bind to overlapping sets of genomic loci and control similar gene expression programs. Using expression data derived from GBM patients, we found that ZFHX4 significantly affects CHD4-mediated gene expression perturbations, which defines ZFHX4 as a master regulator of CHD4. These observations define ZFHX4 as a regulatory factor that links the chromatin-remodeling NuRD complex and the GBM TIC state., American Cancer Society (Postdoctoral Fellowship), American Brain Tumor Association (Discovery Grant), National Institutes of Health (U.S.) (Grant P30CA016672), National Institutes of Health (U.S.) (Grant U24CA143883), European Leukodystrophy Association, Japan. Ministry of Education, Culture, Sports, Science and Technology (MEXT/JSPS (KAKENHI 256701), Broad Institute of MIT and Harvard, National Institutes of Health (U.S.) (NIH (R01GM089652), National Institutes of Health (U.S.) (NIH (U01CA168426), National Institutes of Health (U.S.) (NIH U54CA121852), National Institutes of Health (U.S.) (NIH (R01HG002668), National Institutes of Health (U.S.) (NIH R01CA146455), National Institutes of Health (U.S.) (NIH (R01CA170592), National Institutes of Health (U.S.) (NIH P01CA095616), Sontag Foundation, Goldhirsh Foundation, National Institutes of Health (U.S.) (NIH R01NS080944), Starr Foundation, National Institutes of Health (U.S.) (NIH (R01CA129105), David H. Koch Institute for Integrative Cancer Research at MIT, National Institutes of Health (U.S.) (NIH P01CA142536), National Institutes of Health (U.S.) (NIH U01CA176058), National Institutes of Health (U.S.) (NIH K08NS062907), National Institutes of Health (U.S.) (NIH K12CA090354), American Association for Cancer Research, National Brain Tumor Society (fellowship), Dana-Farber Cancer Institute (Pediatric Low Grade Astrocytoma Program grant), Broad Institute of MIT and Harvard (SPARC grant), Howard Hughes Medical Institute (Investigator)
- Published
- 2014
104. ZFHX4 Interacts with the NuRD Core Member CHD4 and Regulates the Glioblastoma Tumor-Initiating Cell State
- Author
-
Koch Institute for Integrative Cancer Research at MIT, Chudnovsky, Yakov, Kim, Dohoon, Whyte, Warren A., Thiru, Prathapan, Muffat, Julien, Yilmaz, Omer, Mitalipova, Maya, Young, Richard A., Sabatini, David M., Zheng, Siyuan, Bansal, Mukesh, Bray, Mark-Anthony, Gopal, Shuba, Theisen, Matthew A., Bilodeau, Steve, Woolard, Kevin, Lee, Jeongwu, Nishimura, Riko, Sakata, Nobuo, Fine, Howard A., Carpenter, Anne E., Silver, Serena J., Verhaak, Roel G.W., Califano, Andrea, Ligon, Keith L., Mellinghoff, Ingo K., Root, David E., Hahn, William C., Chheda, Milan G., Sabatini, David, Whyte, Warren Anthony, Koch Institute for Integrative Cancer Research at MIT, Chudnovsky, Yakov, Kim, Dohoon, Whyte, Warren A., Thiru, Prathapan, Muffat, Julien, Yilmaz, Omer, Mitalipova, Maya, Young, Richard A., Sabatini, David M., Zheng, Siyuan, Bansal, Mukesh, Bray, Mark-Anthony, Gopal, Shuba, Theisen, Matthew A., Bilodeau, Steve, Woolard, Kevin, Lee, Jeongwu, Nishimura, Riko, Sakata, Nobuo, Fine, Howard A., Carpenter, Anne E., Silver, Serena J., Verhaak, Roel G.W., Califano, Andrea, Ligon, Keith L., Mellinghoff, Ingo K., Root, David E., Hahn, William C., Chheda, Milan G., Sabatini, David, and Whyte, Warren Anthony
- Abstract
Glioblastoma (GBM) harbors subpopulations of therapy-resistant tumor-initiating cells (TICs) that are self-renewing and multipotent. To understand the regulation of the TIC state, we performed an image-based screen for genes regulating GBM TIC maintenance and identified ZFHX4, a 397 kDa transcription factor. ZFHX4 is required to maintain TIC-associated and normal human neural precursor cell phenotypes in vitro, suggesting that ZFHX4 regulates differentiation, and its suppression increases glioma-free survival in intracranial xenografts. ZFHX4 interacts with CHD4, a core member of the nucleosome remodeling and deacetylase (NuRD) complex. ZFHX4 and CHD4 bind to overlapping sets of genomic loci and control similar gene expression programs. Using expression data derived from GBM patients, we found that ZFHX4 significantly affects CHD4-mediated gene expression perturbations, which defines ZFHX4 as a master regulator of CHD4. These observations define ZFHX4 as a regulatory factor that links the chromatin-remodeling NuRD complex and the GBM TIC state., American Cancer Society (Postdoctoral Fellowship), American Brain Tumor Association (Discovery Grant), National Institutes of Health (U.S.) (Grant P30CA016672), National Institutes of Health (U.S.) (Grant U24CA143883), European Leukodystrophy Association, Japan. Ministry of Education, Culture, Sports, Science and Technology (MEXT/JSPS (KAKENHI 256701), Broad Institute of MIT and Harvard, National Institutes of Health (U.S.) (NIH (R01GM089652), National Institutes of Health (U.S.) (NIH (U01CA168426), National Institutes of Health (U.S.) (NIH U54CA121852), National Institutes of Health (U.S.) (NIH (R01HG002668), National Institutes of Health (U.S.) (NIH R01CA146455), National Institutes of Health (U.S.) (NIH (R01CA170592), National Institutes of Health (U.S.) (NIH P01CA095616), Sontag Foundation, Goldhirsh Foundation, National Institutes of Health (U.S.) (NIH R01NS080944), Starr Foundation, National Institutes of Health (U.S.) (NIH (R01CA129105), David H. Koch Institute for Integrative Cancer Research at MIT, National Institutes of Health (U.S.) (NIH P01CA095616), National Institutes of Health (U.S.) (NIH P01CA142536), National Institutes of Health (U.S.) (NIH U01CA176058), National Institutes of Health (U.S.) (NIH K08NS062907), National Institutes of Health (U.S.) (NIH K12CA090354), American Association for Cancer Research, National Brain Tumor Society (fellowship), Dana-Farber Cancer Institute (Pediatric Low Grade Astrocytoma Program grant), Broad Institute of MIT and Harvard (SPARC grant), Howard Hughes Medical Institute (Investigator)
- Published
- 2014
105. Histone Demethylase Jumonji D3 (JMJD3) as a Tumor Suppressor by Regulating p53 Protein Nuclear Stabilization
- Author
-
Ene, Chibawanye I., primary, Edwards, Lincoln, additional, Riddick, Gregory, additional, Baysan, Mehmet, additional, Woolard, Kevin, additional, Kotliarova, Svetlana, additional, Lai, Chen, additional, Belova, Galina, additional, Cam, Maggie, additional, Walling, Jennifer, additional, Zhou, Ming, additional, Stevenson, Holly, additional, Kim, Hong Sug, additional, Killian, Keith, additional, Veenstra, Timothy, additional, Bailey, Rolanda, additional, Song, Hua, additional, Zhang, Wei, additional, and Fine, Howard A., additional
- Published
- 2012
- Full Text
- View/download PDF
106. Gliomagenesis Arising from Pten- and Ink4a/Arf-Deficient Neural Progenitor Cells Is Mediated by the p53-Fbxw7/Cdc4 Pathway, Which Controls c-Myc
- Author
-
Kim, Hong Sug, primary, Woolard, Kevin, additional, Lai, Chen, additional, Bauer, Peter O., additional, Maric, Dragan, additional, Song, Hua, additional, Li, Aiguo, additional, Kotliarova, Svetlana, additional, Zhang, Wei, additional, and Fine, Howard A., additional
- Published
- 2012
- Full Text
- View/download PDF
107. Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
- Author
-
Morgan, Richard A., primary, Johnson, Laura A., additional, Davis, Jeremy L., additional, Zheng, Zhili, additional, Woolard, Kevin D., additional, Reap, Elizabeth A., additional, Feldman, Steven A., additional, Chinnasamy, Nachimuthu, additional, Kuan, Chien-Tsun, additional, Song, Hua, additional, Zhang, Wei, additional, Fine, Howard A., additional, and Rosenberg, Steven A., additional
- Published
- 2012
- Full Text
- View/download PDF
108. Serum S100A6 Concentration Predicts Peritoneal Tumor Burden in Mice with Epithelial Ovarian Cancer and Is Associated with Advanced Stage in Patients
- Author
-
Wei, Bih-Rong, primary, Hoover, Shelley B., additional, Ross, Mark M., additional, Zhou, Weidong, additional, Meani, Francesco, additional, Edwards, Jennifer B., additional, Spehalski, Elizabeth I., additional, Risinger, John I., additional, Alvord, W. Gregory, additional, Quiñones, Octavio A., additional, Belluco, Claudio, additional, Martella, Luca, additional, Campagnutta, Elio, additional, Ravaggi, Antonella, additional, Dai, Ren-Ming, additional, Goldsmith, Paul K., additional, Woolard, Kevin D., additional, Pecorelli, Sergio, additional, Liotta, Lance A., additional, Petricoin, Emanuel F., additional, and Simpson, R. Mark, additional
- Published
- 2009
- Full Text
- View/download PDF
109. Polyomavirus and Naturally Occuring Neuroglial Tumors in Raccoons (Procyon Lotor).
- Author
-
Pesavento, Patricia A., Brostoff, Terza, Church, Molly E., Dela Cruz Jr, Florante N., and Woolard, Kevin D.
- Published
- 2015
- Full Text
- View/download PDF
110. Gliomagenesis Arising from Pten- and Ink4a/Arf-Deficient Neural Progenitor Cells Is Mediated by the p53-Fbxw7/Cdc4 Pathway, Which Controls c-Myc.
- Author
-
Hong Sug Kim, Woolard, Kevin, Chen Lai, Bauer, Peter O., Maric, Dragan, Hua Song, Aiguo Li, Kotliarova, Svetlana, Wei Zhang, and Fine, Howard A.
- Subjects
- *
GLIOBLASTOMA multiforme , *PROGENITOR cells , *P53 antioncogene , *BRAIN tumors , *PHOSPHOINOSITIDES , *STEM cells - Abstract
Glioblastoma multiforme is the most common type of primary malignant brain tumor and may arise from a cell with neural stem-like properties. Deregulation of the retinoblastoma, phosphoinositide-3 kinase (PI3K), and p53 pathways are molecular hallmarks of this disease. Recent work has shown that p53-/-Pten-/- mice form gliomas in a c-Myc--dependent manner. To explore the role of the INK4A/ARF locus and Pten deletions in gliomagenesis, we generated Pten-/-Ink4a/Arf-/-mouse neural stem cells (mNSC) and such cellswere highly proliferative, self-renewing, relatively refractory to differentiation, and induced both low- and high-grade glioma formation in vivo. In contrast to p53-/- Pten-/- mNSCs, however, Pten-/-Ink4a/Arf-/- mNSCs do not express appreciable levels of c-Myc in vitro, although glioma stem cells derived from thesecells did. Sequencing of Pten-/-Ink4a/Arf-/- mNSC--derived tumors revealed spontaneous mutations in Tp53 in vivo with subsequent downregulation of Fbxw7. Expression of p53 mutants in Pten-/-Ink4a/Arf-/- mNSC or knockdown of Fbxw7 resulted in reexpression of c-Myc with enhanced Pten-/-Ink4a/Arf-/- mNSC tumorigenecity. We propose that p53 mutations contribute to gliomagenesis by both allowing the overexpression of c-Myc through downregulation of Fbxw7 and by protecting against c-Myc--induced apoptosis. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
111. Comparative Biology of Glioma Stem Cells and Embryonic Neural Stem Cells in Dogs.
- Author
-
Woolard, Kevin
- Published
- 2010
112. Postmortem diagnoses of spinal ataxia in 316 horses in California.
- Author
-
Hates, Erin N., Aleman, Monica, Marquardt, Sabin A., Katzman, Scott A., Woolard ., Kevin D., Miller, Andrew D., and Finno, Carrie J.
- Subjects
- *
ARABIAN horses , *ATAXIA , *MEDICAL record databases , *HORSES , *DIAGNOSIS , *AUTOPSY , *VETERINARY autopsy - Abstract
OBJECTIVE To determine period prevalences of postmortem diagnoses for spinal cord or vertebral column lesions as underlying causes of ataxia (spinal ataxia) in ANIMALS 2,861 client-owned horses (316 with ataxia [ataxic group] and 2,545 without ataxia [control group]). PROCEDURES The medical records database of the University of California-Davis Veterinary Medical Teaching Hospital was searched to identify horses necropsied between January 1,2005, and December 31, 2017. Results were compared between the ataxic and control groups and between various groups of horses in the ataxic group. Period prevalences were determined for the most common causes of ataxia. RESULTS 2,861 horses underwent full necropsy, and the period prevalences for the most common definitive diagnoses for ataxia were 2.7% (77/2,861) for cervical vertebral compressive myelopathy (CVCM), 1.3% (38/2,861) for equine neuroaxonal dystrophy or equine degenerative myeloencephalopathy (eNAD-EDM), and 0.9% (25/2,861) for trauma; the period prevalence of ataxia of unknown origin was 2.0% (56/2,861). Horses in the ataxic group (vs the control group) were more likely to have been warmblood horses (OR, 2.70) and less likely to have been Arabian horses (OR, 0.53). In the ataxic group, horses < 5 (vs 2 5) years of age had greater odds of CVCM (OR, 2.82) or eNAD-EDM (OR, 6.17) versus trauma or ataxia of unknown origin. Horses in the ataxic group with CVCM were more likely Thoroughbreds (OR, 2.54), whereas horses with eNAD-EDM were more likely American Quarter Horses (OR, 2.95) and less likely Thoroughbreds (OR, 0.11). CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that breed distributions differed for horses with CVCM versus eNAD-EDM; therefore, breed should be considered in the clinical evaluation of spinal ataxia in horses. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
113. Evaluation of accuracy for 18 F-FDG positron emission tomography and computed tomography for detection of lymph node metastasis in canine oral malignant melanoma.
- Author
-
Willcox JL, Spriet M, Zwingenberger AL, Phillips KL, Burton JH, Skorupski KA, Hansen KS, Affolter VK, Woolard KD, Beylin D, and Giuffrida MA
- Subjects
- Animals, Dogs, Fluorodeoxyglucose F18, Lymph Nodes diagnostic imaging, Lymphatic Metastasis diagnostic imaging, Mouth Neoplasms diagnostic imaging, Prospective Studies, Radiopharmaceuticals, Sensitivity and Specificity, Skin Neoplasms, Melanoma, Cutaneous Malignant, Dog Diseases diagnostic imaging, Melanoma diagnostic imaging, Melanoma veterinary, Mouth Neoplasms veterinary, Positron Emission Tomography Computed Tomography veterinary
- Abstract
Tumour stage has been demonstrated to have prognostic significance in canine oral malignant melanoma (OMM). Various evaluation techniques of positron emission tomography/computed tomography (PET/CT) have been reported for staging of head-and-neck tumours in people, but canine-specific data are limited, and reports for CT accuracy have been variable. In this prospective study, the head/neck of client-owned dogs with cytologically or histologically diagnosed OMM were imaged with
18 Fluorine-fluorodeoxyglucose (18 F-FDG) PET/ CT. Bilateral mandibular lymphadenectomy was performed for histopathologic assessment. Two evaluation techniques for CT and PET were applied by four independent observers. CT evaluation utilized both a standardized grading scheme and a subjective clinical interpretation. PET evaluation was first performed solely on18 F-FDG-uptake in lymph nodes compared to background on a truncated scan excluding the oral cavity. Subsequently, the entire head/neck scan and standardized uptake value (SUV) measurements were available. Receiver operating characteristic analysis was performed with histopathology as gold standard. Twelve dogs completed the study and metastatic OMM was identified in six mandibular lymph nodes from five dogs. Of the CT-interpretation techniques, use of clinical grading performed best (sensitivity = 83% and specificity = 94%). Both PET techniques resulted in 100% sensitivity, but primary tumour site evaluation and use of SUV increased specificity from 78% to 94%. The SUVmax cut-point, 3.3, led to 100% sensitivity and 83% specificity. In this population of dogs, PET appeared to be highly sensitive but at risk of being less specific without use of appropriate parameters and thresholds., (© 2020 John Wiley & Sons Ltd.)- Published
- 2021
- Full Text
- View/download PDF
114. Clearance of a dermal Huffmanela sp. in a sandbar shark (Carcharhinus plumbeus) using levamisole.
- Author
-
MacLean RA, Fatzinger MH, Woolard KD, and Harms CA
- Subjects
- Animals, Antinematodal Agents pharmacology, Female, Fish Diseases parasitology, Levamisole pharmacology, Nematoda drug effects, Nematode Infections drug therapy, Ovum cytology, Skin parasitology, Skin Diseases, Parasitic veterinary, Treatment Outcome, Antinematodal Agents administration & dosage, Fish Diseases drug therapy, Levamisole administration & dosage, Nematoda isolation & purification, Nematode Infections veterinary, Sharks parasitology
- Abstract
A wild-caught captive sandbar shark Carcharhinus plumbeus developed a contiguous network of darkly pigmented linear tracks that progressed from the snout to the ventral cervical region. Microscopic examination of a skin scraping revealed nematode eggs of the genus Huffmanela, a group of histozoic nematodes that is known to parasitize requiem sharks and marine and freshwater teleosts. The fresh eggs were darkly pigmented with bipolar plugs, contained a larva, and measured 73.3 to 86.4 by 39.0 to 47.4 microm (n = 10). Formalin-fixed and paraffin-embedded eggs were significantly smaller (Wilcoxon rank sums test, p < 0.005), measuring 70.5 to 78.9 by 33.6 to 41.3 microm (n = 13). These measurements do not correlate with previously reported species of Huffmanela. Serial treatment with levamisole (10 mg kg(-1), intramuscular [i.m.]) cleared the egg tracks within 21 d, with no recurrence or apparent complications.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.